APO-NALTREXONE
APOTEX INC
Quick answers
Is there a shortage of APO-NALTREXONE in Canada?
No. There is no current shortage of APO-NALTREXONE 50MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
REVIA - TAB 50MG
DUPONT MERCK PHARMA INC.
REVIA
TEVA CANADA LIMITED
NALTREXONE HYDROCHLORIDE TABLETS USP
STERINOVA INC.
RPC-NALTREXONE
RUSAN PHARMA CANADA INC.
DIN
02444275
Strength
50MG
Dosage Form
Tablet
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178